Findings of a recent survey including 94 radiologists from 30 different countries were recently published in ״Current Problems in Diagnostic Radiology״. The findings revealed that: * 62% of those surveyed observed retention of gadolinium (Gd) in the brain on MRI studies. * Of the 62%, only half reported the finding. * 58% do not or wouldn’t include Gd retention in their report. * 12% included Gd retention in their report. * 29% did not report Gd retention for fear of provoking patient anxiety. * 28% report changing their use of Gd due to the recent data about its accumulation in the brain. Dr. Vikas Agarwal of the University of Pittsburgh Medical Center, a corresponding author, stated that some radiologists and their practices are not waiting for evidence that Gd accumulation is harmful and instead are proactively making changes in the way they utilize gadolinium based contrast agents. He went on to say that “Time will tell whether or not Gd represents a real risk to our patients. Until we know whether intracranial Gd has negative health consequences, radiologists must be cognizant of the way in which we report the imaging manifestations of Gd in the brain and consider the potential impact of what we report on our patients, referring physicians, and ourselves”. To find out more, visit: http://www.healthimaging.com/topics/practice-management/study-58-percent-radiologists-don-t-include-brain-gd-reports Please join the growing list of advocates and sign our petition so we can help promote the development of safer alternatives and effective treatments to remove gadolinium from patients affected by it.